After 27 years in business, Cytokinetics hopes to pit its own cardiac myosin inhibitor against one it initially developed—now owned by Bristol Myers Squibb—in a market worth billions. Aficamten has a ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...

Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH December 19, 2025 8:00 AM ...

Acute respiratory distress syndrome (ARDS) remains a major challenge in critical care, with mortality rates often exceeding 35–40%. Mechanical ...

Abstract: Most palm oil processing mills in Malaysia use traditional wet chemical analysis as a standard reference measurement method to determine free fatty acids (FFA) as prescribed by the Malaysian ...

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for ...

ARDS is a life-threatening lung condition causing severe breathing failure. New research shows AI could personalize ...

Average weight loss of ~17% if all patients stayed on treatment* with Wegovy® (semaglutide) tablets 25 mg (~14% regardless of if patients stayed on ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Six days after a senior FDA official sent a sweeping internal email claiming that covid vaccines had caused the deaths of “at ...